NCT01160224View on ClinicalTrials.gov

Oral GW766944 (Oral CCR3 Antagonist)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 8, 2010

Primary Completion Date

August 29, 2011

Study Completion Date

August 29, 2011

Conditions
Asthma
Interventions
DRUG

GW766944

Drug: GW766944 (Active Drug Treatment)

OTHER

Placebo

This is placebo to match.

Trial Locations (5)

T2N 4Z6

GSK Investigational Site, Calgary

L8N 4A6

GSK Investigational Site, Hamilton

H2X 2P4

GSK Investigational Site, Montreal

H4J 1C5

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Québec

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY